- Nachrichtendetail
-
06.03.2024 15:07:00 - dpa-AFX: *J&J SEEKS EMA APPROVAL FOR DARZALEX QUADRUPLET THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Xetra | 140,460 | 14.05.24 10:48:25 | +0,840 | +0,60% | 140,200 | 140,580 | 139,980 | 139,620 |
